<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Evelabs - Medium]]></title>
        <description><![CDATA[Hello - Medium]]></description>
        <link>https://medium.com/evelabs?source=rss----ecc32b182e82---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>Evelabs - Medium</title>
            <link>https://medium.com/evelabs?source=rss----ecc32b182e82---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 04:07:35 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/evelabs" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Design inputs for Medical Device — Points to Remember]]></title>
            <link>https://medium.com/evelabs/design-inputs-for-medical-device-points-to-remember-222f81303dc8?source=rss----ecc32b182e82---4</link>
            <guid isPermaLink="false">https://medium.com/p/222f81303dc8</guid>
            <category><![CDATA[control-design]]></category>
            <category><![CDATA[product-lifecycle]]></category>
            <category><![CDATA[medical-devices]]></category>
            <dc:creator><![CDATA[Evelabs]]></dc:creator>
            <pubDate>Fri, 13 Oct 2017 03:07:19 GMT</pubDate>
            <atom:updated>2017-10-13T03:07:18.978Z</atom:updated>
            <content:encoded><![CDATA[<ol><li>Design Inputs can be of these types. according to ISO13485</li></ol><blockquote>functional, performance, usability and safety requirements, according to the intended use</blockquote><blockquote>applicable regulatory requirements and standards;</blockquote><blockquote>applicable output(s) of risk management;</blockquote><blockquote>appropriate, information derived from previous similar designs;</blockquote><blockquote>other requirements essential for design and development of the product and processes.</blockquote><p>2. Design inputs should be objective — It should be written in such a way that it can be tested/inspected or analysed during design verification.</p><p>3. Design inputs should not conflict with each other.</p><p>4. The design input requirements shall be documented and shall be reviewed and approved by a designated individual(s). The approval, including the date and signature of the individual(s) approving the requirements, shall be documented.</p><p>5. Design inputs should be measurable and if the device has interfaces it would be better to keep a separate usability engineering file to add usability requirements.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=222f81303dc8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/evelabs/design-inputs-for-medical-device-points-to-remember-222f81303dc8">Design inputs for Medical Device — Points to Remember</a> was originally published in <a href="https://medium.com/evelabs">Evelabs</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Designing for IoMT ( Internet of Medical Things)]]></title>
            <link>https://medium.com/evelabs/designing-for-networks-afe2a74104ba?source=rss----ecc32b182e82---4</link>
            <guid isPermaLink="false">https://medium.com/p/afe2a74104ba</guid>
            <dc:creator><![CDATA[vishnu ms]]></dc:creator>
            <pubDate>Thu, 19 Jan 2017 06:17:11 GMT</pubDate>
            <atom:updated>2017-03-08T16:31:57.915Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/886/1*vnCqnf9ACbkWOTQtjk3jfA.jpeg" /><figcaption>Actor Network in Government General Hospital, Trivandrum. Figure shows <strong>information[red]</strong> and<strong> action [blue]</strong> between different actors in the network.</figcaption></figure><p>Connected devices are not just pieces of hardware. They change the nature of the network of people, places and things. Designing connected devices for hospitals involves the study of the ecosystem in which these devices exists and how the nodes of the networks ( Patients, By standers, Stands, Medical devices etc) interact with each other. A smart infusion device acts on the network of a people in many ways.</p><h4>Information flow</h4><p>Information about drip completion was usually passed by-stander to the nurse. But this, was often obstructed in various flows as caretakers used to go outside or patients were sleeping, though there were lot of other actors in the system. This information will be directly conveyed to the nursing station with a smart infusion monitor.</p><h4>Power relations</h4><p>Smart devices with its access to information can bring in curated information and suggestions to the nurses altering the power relations and knowledge gap between nurses and doctors.</p><h4>Temporal awareness</h4><p>Information of drip completion will be readily available to the nurse at hand. Nurse can take informed decisions to manage her time effectively.</p><h4>Glocalized Information</h4><p>The information nevertheless remains local, it surpasses the ward level and leaves global. This increases the implication up on security in patient data and designing of such system should be done with security as a major priority.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=afe2a74104ba" width="1" height="1" alt=""><hr><p><a href="https://medium.com/evelabs/designing-for-networks-afe2a74104ba">Designing for IoMT ( Internet of Medical Things)</a> was originally published in <a href="https://medium.com/evelabs">Evelabs</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Assure Quality Healthcare at Home with IoT]]></title>
            <link>https://medium.com/evelabs/assure-quality-healthcare-at-home-with-iot-6edba6c88ec2?source=rss----ecc32b182e82---4</link>
            <guid isPermaLink="false">https://medium.com/p/6edba6c88ec2</guid>
            <category><![CDATA[nursing-and-home-care]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[iot]]></category>
            <dc:creator><![CDATA[Sruthy Venugopal]]></dc:creator>
            <pubDate>Tue, 17 Jan 2017 11:14:49 GMT</pubDate>
            <atom:updated>2017-01-17T11:14:49.358Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*SbOxPu46tmayZ-Vqc2zAAg.jpeg" /></figure><p>By 2050, <a href="http://www.forbes.com/sites/benjaminshobert/2014/08/11/indias-home-healthcare-heats-up/#36f5aaa24024">according to statistics</a>, India’s 60 plus population will have grown from today’s 100 million to over 300 million. China, a country facing a similar crisis, envisions to serve their ageing population’s health care needs in a <a href="https://healthintelasia.com/creating-home-healthcare-industry-china/">90–7–3 strategy</a>, where 90% will get home health care, 7% through community hospitals and 3% approach private nursing homes. While China’s ageing industry has garnered massive attention from international players and its government, senior care in India is largely neglected — probably because of a highly stratified market, the extent of behavioural change required and most importantly, insufficient infrastructure. Since the first two are inevitable, let’s discuss the third.</p><p>A few weeks back, a startup company representative from the blooming <a href="https://yourstory.com/2016/05/house-healthcare-startup/">home healthcare industry</a> of India, gave us a ring. She wanted to see the feasibility of <a href="http://evelabs.co/">Dripo</a> in home healthcare. The discussion was insightful as it opened up to us an important market segment, largely neglected earlier. She asked whether Dripo could help a physician remotely monitor the course of infusion given at home. We assured her it will do a lot more, like monitoring the status of every infusion and alert the nurse on completion etc, which will save the time spent in IV therapy.</p><p>In home health care environment, the nurse-physician work relationship involves less direct physician contact, and the physician relies to a greater degree on the nurse to make assessments and communicate findings. We identify two major issues in the home healthcare industry of India. First, many service providers, like our prospect client, are worried about <a href="https://www.ncbi.nlm.nih.gov/books/NBK2631/">patient safety and care quality</a> in a home care setting. It is always important to keep an eye on treatments like IV therapy since the potential of medication errors among the home health care population is greater than in other health care settings. Second, shortage of nurses and allied health professionals make home health care unaffordable for a huge share of the ageing population.</p><p>Connected healthcare devices are an ideal solution for home care service providers. They can make medical technology part of homes for an affordable price. Connected healthcare is a mechanism that relieves the pressure on health practitioners currently pushed to their limits and ultimately delivers better, more efficient patient care.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6edba6c88ec2" width="1" height="1" alt=""><hr><p><a href="https://medium.com/evelabs/assure-quality-healthcare-at-home-with-iot-6edba6c88ec2">Assure Quality Healthcare at Home with IoT</a> was originally published in <a href="https://medium.com/evelabs">Evelabs</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Way beyond pump v/s gravity arguments]]></title>
            <link>https://medium.com/evelabs/way-beyond-88b224614e89?source=rss----ecc32b182e82---4</link>
            <guid isPermaLink="false">https://medium.com/p/88b224614e89</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[cancer]]></category>
            <dc:creator><![CDATA[Evelabs]]></dc:creator>
            <pubDate>Sun, 08 Jan 2017 12:01:52 GMT</pubDate>
            <atom:updated>2017-01-17T11:06:43.806Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*v4u7nONzL2iJm8j8sFTv5w.jpeg" /></figure><p><strong>There is an interesting discussion titled </strong><a href="http://allnurses.com/general-nursing-discussion/pump-vs-gravity-898264.html"><strong>‘Pump Vs Gravity’</strong></a><strong> in an online group exclusive for nurses. The discussion starts with a question post from a dedicated Nurse, who works in oncology/haematology department. Puzzled to see all chemo and biologics in her workplace run via gravity only, she asks “Is this unusual?”. And then paused a question whether the rest of the community uses a pump or gravity for chemo and biologics.</strong></p><p><strong>In the comments section, some nurses said running chemo on gravity is too risky as the prescription rates are very precise and even a slight variation medicine might cause serious harm. Many admitted that they use gravity drips only but it is an undesirable way of administering cancer drugs. A rational health practitioner observed, probably the hospitals are trying to save money spend on pumps and thus puts the safe administration all on the shoulders of the nurse with little or no protection in place. Many nurses use and advice to use flow regulators for longer infusions.</strong></p><p><strong>As many nurses in the discussion rightly pointed out, Chemotherapy agents have a narrow </strong><a href="https://en.wikipedia.org/wiki/Therapeutic_index"><strong>therapeutic index</strong></a><strong>; even minor errors potentially can cause serious harm. And, hence it has to be considered as a “high-alert” medication. Almost every available literature on safe practices for chemotherapy insists medication through infusion pumps. But, even the best technology cannot eliminate errors completely.</strong></p><p><strong>Examples of chemotherapy errors include chemotherapy administration to the wrong patient, chemotherapy under- and overdosing, and incorrect route, rate, and time of administration. If treatment plans and chemotherapy orders are not verified during each treatment, errors may be repeated during subsequent chemotherapy treatments and go undetected throughout an entire treatment course. And moreover, sometimes the complicated interface of this automated interfaces lead to lethal administration errors as in </strong><a href="https://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=111"><strong>these cases reported</strong></a><strong> by ISMP safe medication alert.</strong></p><p><a href="http://theoncologist.alphamedpress.org/content/11/5/463.full"><strong>Experts recommend</strong></a><strong> using precision infusion apparatus and identification systems to reduce administration errors in chemotherapy, besides having an accurate, unambiguous order and continuous staff training. To avoid prescription errors, many </strong><a href="https://www.ncbi.nlm.nih.gov/books/NBK43752/"><strong>recent studies </strong></a><strong>advice to use smart infusion devices with expandable medicine libraries.</strong></p><p><strong>However, adoption of high-end IOT infusion pumps for every chemotherapy may not be a viable solution, considering the number of cancer patients increase per year and expected to rise by 70% in the next two decades, </strong><a href="http://www.who.int/mediacentre/factsheets/fs297/en/"><strong>according to WHO</strong></a><strong>. And it is high time to look into alternatives — new age affordable precision infusion solutions — for chemotherapy.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=88b224614e89" width="1" height="1" alt=""><hr><p><a href="https://medium.com/evelabs/way-beyond-88b224614e89">Way beyond pump v/s gravity arguments</a> was originally published in <a href="https://medium.com/evelabs">Evelabs</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>